High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease.Published in:Movement Disorders, 2020, v. 35, n. 10, p. 1822, doi. 10.1002/mds.28186By:Klatt‐Schreiner, Katharina;Valek, Lucie;Kang, Jun‐Suk;Khlebtovsky, Alexander;Trautmann, Sandra;Hahnefeld, Lisa;Schreiber, Yannick;Gurke, Robert;Thomas, Dominique;Wilken‐Schmitz, Annett;Wicker, Sabine;Auburger, Georg;Geisslinger, Gerd;Lötsch, Jörn;Pfeilschifter, Waltraud;Djaldetti, Ruth;Tegeder, IrmgardPublication type:Article